Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin.

about

Interference of P-REX2a may inhibit proliferation and reverse the resistance of SGC7901 cells to doxorubicin.

Item

http://www.wikidata.org/entity/Q49703984

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@en

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@nl

type

Item

label

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@en

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@nl

prefLabel

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@en

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@nl

P1476

Interference of P-REX2a may in ...... SGC7901 cells to doxorubicin.

@en

P2093

Jingbo Han

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Mingwen Guo

http://www.w3.org/2001/XMLSchema#string

Qiaohui Zhou

http://www.w3.org/2001/XMLSchema#string

Yaowei Ai

http://www.w3.org/2001/XMLSchema#string

Zhihong Pan

http://www.w3.org/2001/XMLSchema#string

P2860

P-Rex2, a new guanine-nucleotide exchange factor for Rac

Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a

Global cancer statistics, 2012

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

PTEN: one gene, many syndromes

PI3K-Akt pathway: its functions and alterations in human cancer.

Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance.

Inhibition of PI3K/Akt/mTOR signaling pathway enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin in vitro.

P-REX2a driving tumorigenesis by PTEN inhibition.

Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro

P304

3185-3191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7693

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29435055

http://www.w3.org/2001/XMLSchema#string

P932

5778894

http://www.w3.org/2001/XMLSchema#string